VA
NHC icon

Vident Advisory’s National Healthcare NHC Stock Holding History

Vident Advisory’s Portfolio NHC Stock Details NHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Sell
14,958
-450
-3% -$82.6K 0.02% 519
2026
Q1 		$2.46M Buy
15,408
+167
+1% +$25.6K 0.02% 561
2025
Q4 		$2.09M Sell
15,241
-2,418
-14% -$312K 0.02% 568
2025
Q3 		$2.15M Sell
17,659
-858
-5% -$92.6K 0.02% 559
2025
Q2 		$1.98M Buy
18,517
+20
+0.1% +$2K 0.02% 502
2025
Q1 		$1.72M Sell
18,497
-758
-4% -$73.4K 0.03% 530
2024
Q4 		$2.07M Sell
19,255
-9,233
-32% -$1.12M 0.04% 409
2024
Q3 		$3.58M Buy
28,488
+1,596
+6% +$201K 0.09% 228
2024
Q2 		$2.92M Buy
26,892
+948
+4% +$92.4K 0.08% 264
2024
Q1 		$2.45M Buy
25,944
+1,306
+5% +$124K 0.05% 336
2023
Q4 		$2.28M Buy
24,638
+9,701
+65% +$743K 0.06% 346
2023
Q3 		$956K Buy
+14,937
New +$957K 0.03% 524

Other funds holding NHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.07B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vident Advisory's NHC Position: Q2 2026 in Review

Vident Advisory reduced its National Healthcare (NHC) stake by 2.9% in Q2 2026, selling an estimated $82.6K and leaving 14,958 shares worth $3.16M. The position accounts for 0.02% of the portfolio, ranked #519.

Vident Advisory first reported a position in NHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.58M in Q3 2024. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Vident Advisory held 14,958 shares of National Healthcare worth $3.16M as of Q2 2026.
  • Vident Advisory sold 450 National Healthcare shares in Q2 2026, an estimated $82.6K.
  • National Healthcare made up 0.02% of Vident Advisory's portfolio in Q2 2026, its #519 holding.
  • Vident Advisory first reported a position in National Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Vident Advisory's National Healthcare position peaked at $3.58M in Q3 2024.
  • 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.